main street realty & management LLC

p.o. box 730
fishkill, new york 12524

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 04, 2014

NYS DOS ID#
4538287

County
DUTCHESS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - MAIN STREET REALTY & MANAGEMENT LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Get ready for 'spring cleaning' in foreclosures
    By podcast@wsj.com (MarketWatch.com) - Thursday Dec 11, 2014

    RealtyTrac sees foreclosures at pre-recession levels early next year, and banks gearing up for some "spring cleaning."

    Source: The Wall Street Journal: MarketWatch News Break
  • Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
    Tuesday Jun 13, 2017

    Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.

    Source: The Wall Street Journal: U.S. Business
  • Listing of the Day: Maine
    Friday Oct 6, 2017

    While being so close to the bustling city, House Island is unique in that it still manages to feel very separate and private.

    Source: The Wall Street Journal: Most Popular
  • Sunday Routine: How Sheryll Durrant, Urban Farmer, Spends Her Sundays
    By SHIVANI VORA - Friday Sep 15, 2017

    The resident manager of the Kelly Street Garden, in South Bronx’s Longwood neighborhood, sleeps in and spends time with her husband and teenage son.

    Source: NYT > Home Page
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed